The Role of NLRP1 , AIM2 and MEFV Inflammasomes in the High‐Intensity Interval Training of Individuals With Obesity
Immunology · 2025
DOI: 10.1111/imm.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Ana Luíza Pereira Assunção Silveira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Post Graduation Program in Health Sciences, Santo Amaro University, São Paulo, Brazil. Hauptthemen laut MEDLINE: Inflammasomes, Obesity, Pyrin, High-Intensity Interval Training. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Obesity is a chronic disease associated with systemic inflammation caused by excess visceral fat and pro‐inflammatory cytokines such as IL‐1β and IL‐6. Inflammasomes—particularly those involving genes such as NLRP1, AIM2 and MEFV—play a key role in this process. High‐intensity interval training (HIIT) can counteract this inflammation; however, it remains unclear how HIIT modulates inflammasome gene expression in obesity. This study investigated whether HIIT can alter the expression of genes related to the inflammasomes NLRP1, AIM2 and MEFV in obese individuals. The results showed that, after 8 weeks of HIIT, there was an increase in the expression of the genes AIM2, MEFV, CARD16 and CARD18. The increase in CARD16, known to inhibit caspase‐1 dimerisation, reinforces the hypothesis related to decreased inflammation, evidenced by the absence of clear activation of the NLRP1 inflammasome and by lower serum IL‐1β concentrations in trained participants. Although CARD18 was also upregulated, its function remains ambiguous, and it may act as an inhibitor or modulator of inflammation. Therefore, we conclude that HIIT is a promising intervention for modulating inflammatory genes in individuals with obesity, with the potential to reduce systemic inflammation and its pathological effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Post Graduation Program in Health Sciences, Santo Amaro University, São Paulo, Brazil.
- ENT Research Lab, Department of Otorhinolaryngology-Head and Neck Surgery, Federal University of Sao Paulo, São Paulo, Brazil.
ORCID-Profile: André Luis Lacerda Bachi, Carolina Nunes França
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Silveira, A. L. P. A., Abreu, D. A., Musto, A. L. S., Nali, L. H. D. S., Amaral, J. B. D., Bachi, A. L. L., Shio, M. T., Rezende-Teixeira, P., & França, C. N. (2025). The Role of NLRP1 , AIM2 and MEFV Inflammasomes in the High‐Intensity Interval Training of Individuals With Obesity. Immunology. https://doi.org/10.1111/imm.70090
Vancouver
Silveira ALPA, Abreu DA, Musto ALS, Nali LHDS, Amaral JBD, Bachi ALL, et al. The Role of NLRP1 , AIM2 and MEFV Inflammasomes in the High‐Intensity Interval Training of Individuals With Obesity. Immunology. 2025. doi:10.1111/imm.70090
BibTeX
@article{Silveira2025,
author = {Silveira, Ana Luíza Pereira Assunção and Abreu, Daniela Alves de and Musto, Amanda de Lima Santos and Nali, Luiz Henrique da Silva and Amaral, Jônatas Bussador do and Bachi, André Luis Lacerda and Shio, Marina Tiemi and Rezende-Teixeira, Paula and França, Carolina Nunes},
title = {The Role of NLRP1 , AIM2 and MEFV Inflammasomes in the High‐Intensity Interval Training of Individuals With Obesity},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.70090}
}
EUVIMED